BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Emerging Biotech

PRISM BioLab Secures 1.5 Billion Yen in Series C Funding for Advancing Protein-Protein Interaction Technologies

PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein int...

January 25, 2024 | News

PeproMene Bio Reports Successful B-ALL Treatment in Phase 1 Trial at City of Hope

This result adds to the presentation of PeproMene Bio's clinical trial of PMB-CT01 in relapsed/refractory non-Hodgkin's lymphoma at last month's Ameri...

January 18, 2024 | News

FUST Lab's DEBREX Nano-Emulsion Equipment Launches in Japan

Dispersion/emulsification technology (technology for mixing two or more immiscible substances) is a key technology used in various productions such as cosm...

January 16, 2024 | News

Novogene Expands Global Presence with Increased PacBio Revio Fleet for Enhanced Long-Read Sequencing Applications

Novogene aims to strengthen its service offerings in long-read sequencing applications with PacBio latest Revio sequencer. As an early adopter of PacBio Re...

January 10, 2024 | News

Medison Pharma to Commercialize Regeneron's Libtayo® in Multiple Countries

Libtayo (cemiplimab) is a leading PD-1 inhibitor that has shown efficacy in the treatment of certain patients with cutaneous squamous cell carcinoma, adv...

January 09, 2024 | News

Clarametyx Biosciences Secures $33M in Series A Funding for Anti-Biofilm Biologics Development

Clarametyx Biosciences Inc. (“Clarametyx”), a clinical stage company developing targeted, immune-enabling biologic therapies to counter persist...

January 08, 2024 | News

JW Therapeutics' supplemental license application for Carteyva® in relapsed or refractory Mantle Cell Lymphoma has been accepted by the NMPA.

JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immun...

January 05, 2024 | News

Turn Biotechnologies Unveils Enhanced eTurna™ Platform to Address Industry's Delivery Challenges

Company announces development of novel ionizable lipids and stabilizing components eTurna™ delivery platform expected to improve safety, redu...

January 04, 2024 | News

Atal Incubation Centre - CCMB and Thermo Fisher Scientific Join Forces to Drive Innovation in Startup Ecosystem

At the heart of this partnership lies the establishment of a cutting-edge laboratory, outfitted with state-of-the-art, high-end equipment generously provid...

January 03, 2024 | News

HeraNova Lifesciences Raises $13.5M in Seed Funding for Women's Health Solutions

Heranova Lifesciences Holding Ltd. ("Heranova") announced the successful completion of a USD 13.5 million seed and seed+ financing to devel...

December 29, 2023 | News

Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024

Unveiling the Pioneering Companies Poised to Transform Healthcare 1. QuantumGen Website: quantumgen.com Location: San Francisco, CA, USA Focu...

December 29, 2023 | News

FDA Grants Orphan Drug Designation to Boan Biotech's Two Novel Claudin 18.2 Drugs.

Orphan drugs, also known as drugs for rare diseases, are drugs for preventing, treating or diagnosing rare diseases. Being designated as orphan drugs will ...

December 28, 2023 | News

Nectin Therapeutics Expands Clinical Trial to Israel, Progresses Swiftly

Nectin Therapeutics Ltd., (Nectin), a biotechnology company developing novel targeted immunotherapies that address resistance to approved immune oncology t...

December 27, 2023 | News

Astellas Completes Acquisition of Propella Therapeutics

Through the acquisition of Propella, Astellas has acquired PRL-02 (abiraterone decanoate), a next-generation androgen biosynthesis inhibitor being develope...

December 22, 2023 | News

Stay Connected